<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Octamer-binding transcription factor 4 (OCT4) has been implicated in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>In this study, we investigated whether OCT4 promotes <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> through the epithelial-mesenchymal transition (EMT) process </plain></SENT>
<SENT sid="2" pm="."><plain>We designed our experiment as a loss-of-function study </plain></SENT>
<SENT sid="3" pm="."><plain>Western blot analysis was used to measure the extent and stability of OCT4 knockdown </plain></SENT>
<SENT sid="4" pm="."><plain>We evaluated the metastatic phenotype of OCT4-silenced SW620 cells using standard migration and invasion assays in vitro and the commonly used mouse model for experimental <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> in vivo </plain></SENT>
<SENT sid="5" pm="."><plain>We found that OCT4 knockdown inhibited <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cell motility and invasion (in vitro) and decreased hepatic colonization (in vivo) </plain></SENT>
<SENT sid="6" pm="."><plain>It also induced changes in EMT characteristic cell <z:mp ids='MP_0000002'>morphology</z:mp> and marker gene expression </plain></SENT>
<SENT sid="7" pm="."><plain>In addition, its knockdown decreased WNT pathway activity </plain></SENT>
<SENT sid="8" pm="."><plain>Finally, in human primary <z:e sem="disease" ids="C1527249" disease_type="Neoplastic Process" abbrv="">colorectal cancers</z:e>, the frequency of upregulated OCT4 expression in cases with <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastasis</z:e> was statistically higher than that in cases without <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastasis</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>These results indicate that OCT4 may contribute to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cell <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> through EMT and serves as a promising biomarker for identifying <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> patients at high risk for <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastases</z:e> </plain></SENT>
</text></document>